Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

April 25, 2024

Study Completion Date

April 26, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

Obicetrapib

oral administration

DRUG

Obicetrapib + Drospirenone / Ethinyl Estradiol (COC)

oral administration

DRUG

Drospirenone / Ethinyl Estradiol (COC)

oral administration

Trial Locations (1)

89121

NOVUM, Las Vegas

Sponsors
All Listed Sponsors
collaborator

Novum

INDUSTRY

lead

NewAmsterdam Pharma

INDUSTRY